Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-22,100
Closed -$5.49M – 773
2019
Q3
$5.49M Buy
+22,100
New +$4.98M 0.03% 493
2018
Q4
– Sell
-28,500
Closed -$5.36M – 671
2018
Q3
$5.36M Buy
+28,500
New +$5.71M 0.03% 449

Other funds holding ASML

Calamos Advisors's ASML Position: Q2 2026 in Review

Calamos Advisors reduced its ASML (ASML) stake by 50% in Q2 2026, selling an estimated $11.7M and leaving 7,327 shares worth $14.6M. The position accounts for 0.05% of the portfolio, ranked #339.

Calamos Advisors first reported a position in ASML in Q4 2017 and has held it in 28 quarters since. The position peaked at $29M in Q4 2021. 2,515 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Calamos Advisors held 7,327 shares of ASML worth $14.6M as of Q2 2026.
  • Calamos Advisors sold 7,380 ASML shares in Q2 2026, an estimated $11.7M.
  • ASML made up 0.05% of Calamos Advisors's portfolio in Q2 2026, its #339 holding.
  • Calamos Advisors first reported a position in ASML in Q4 2017 and has held it in 28 quarters since.
  • Calamos Advisors's ASML position peaked at $29M in Q4 2021.
  • 2,515 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.